Adverum Biotechnologies Inc
NASDAQ:ADVM

Watchlist Manager
Adverum Biotechnologies Inc Logo
Adverum Biotechnologies Inc
NASDAQ:ADVM
Watchlist
Price: 4.36 USD Market Closed
Market Cap: 96.3m USD

Intrinsic Value

The intrinsic value of one ADVM stock under the Base Case scenario is 0.06 USD. Compared to the current market price of 4.36 USD, Adverum Biotechnologies Inc is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ADVM Intrinsic Value
0.06 USD
Overvaluation 99%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Adverum Biotechnologies Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ADVM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ADVM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Adverum Biotechnologies Inc.

Explain Valuation
Compare ADVM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ADVM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Adverum Biotechnologies Inc

Current Assets 28.9m
Cash & Short-Term Investments 26.1m
Other Current Assets 2.8m
Non-Current Assets 43.5m
PP&E 39.5m
Other Non-Current Assets 4m
Current Liabilities 44.7m
Accounts Payable 12.5m
Accrued Liabilities 32.3m
Non-Current Liabilities 83.3m
Other Non-Current Liabilities 83.3m
Efficiency

Free Cash Flow Analysis
Adverum Biotechnologies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Adverum Biotechnologies Inc

Revenue
0 USD
Operating Expenses
-90.6m USD
Operating Income
-90.6m USD
Other Expenses
2.1m USD
Net Income
-88.6m USD
Fundamental Scores

ADVM Profitability Score
Profitability Due Diligence

Adverum Biotechnologies Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
18/100
Profitability
Score

Adverum Biotechnologies Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

ADVM Solvency Score
Solvency Due Diligence

Adverum Biotechnologies Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
41/100
Solvency
Score

Adverum Biotechnologies Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ADVM Price Targets Summary
Adverum Biotechnologies Inc

Wall Street analysts forecast ADVM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADVM is 5 USD with a low forecast of 4.04 USD and a high forecast of 5.78 USD.

Lowest
Price Target
4.04 USD
7% Downside
Average
Price Target
5 USD
15% Upside
Highest
Price Target
5.78 USD
32% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Adverum Biotechnologies Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ADVM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ADVM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ADVM stock?

The intrinsic value of one ADVM stock under the Base Case scenario is 0.06 USD.

Is ADVM stock undervalued or overvalued?

Compared to the current market price of 4.36 USD, Adverum Biotechnologies Inc is Overvalued by 99%.

Back to Top